Grade 3 Follicular Lymphoma — Trials

Grade 3 Follicular Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

214 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 50
Recruiting: 21
Ph III recruiting: 0
Growth YoY: —
Industry share: 14%
Top sponsor: City of Hope Medical Center
Termination share: 31.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (38)

clinicaltrialsPublishedShowing 51–53 of 53 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06093841	Relmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHL	active not recruiting	Phase 2	46	Shanghai Ming Ju Biotechnology Co., Ltd.INDUSTRY	1	Feb 11, 2025	clinicaltrials
NCT06287398	Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL	recruiting	Phase 2	39	Australasian Leukaemia and Lymphoma GroupOTHER	1	Jul 22, 2024